OR WAIT 15 SECS
Medidata has signed a multi-year deal with South Koreas Hanmi Pharmaceuticals.
Medidata has signed a multi-year deal with South Korea's Hanmi Pharmaceuticals. The Seoul-based company is adopting Medidatas Clinical Cloud platform into all clinical trials across its drug development programs.
Read the full release here